Sarepta Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sarepta Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 33% to $1,243,336,000. The net income raised on -$535,977,000 and profit margin reached -43%. Total operating expenses were $1,360,817,000.
Profit Margin
| 2014 | 9.75M | -135.78M | -1391.71% |
|---|---|---|---|
| 2015 | 1.25M | -220.03M | -17560.26% |
| 2016 | 5.42M | -267.26M | -4930.18% |
| 2017 | 154.58M | -50.68M | -32.79% |
| 2018 | 301.03M | -361.91M | -120.22% |
| 2019 | 380.83M | -715.07M | -187.77% |
| 2020 | 540.09M | -554.12M | -102.6% |
| 2021 | 701.88M | -418.78M | -59.66% |
| 2022 | 933.01M | -703.48M | -75.4% |
| 2023 | 1.24B | -535.97M | -43.11% |
SRPT Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.24B | 933.01M | 701.88M | 540.09M | 380.83M | 301.03M | 154.58M | 5.42M | 1.25M | 9.75M |
Cost of revenue | 150.34M | 139.98M | 97.04M | 63.38M | 56.58M | 34.19M | 7.35M | 130K | 146.19M | 94.10M |
Gross profit | 1.09B | 793.02M | 604.83M | 476.71M | 324.24M | 266.84M | 147.23M | 5.29M | -144.94M | -84.34M |
Operating exp. | ||||||||||
Research and development | 877.38M | 877.09M | 771.18M | 722.34M | 560.90M | 401.84M | 166.70M | 188.27M | 146.39M | 94.23M |
Selling and marketing | 28.6M | 14.6M | 7.7M | 0 | 0 | -2.22M | 2.83M | 2.54M | 0 | 0 |
Total operating expenses | 1.36B | 1.32B | 1.05B | 1.04B | 846.57M | 610.46M | 290.44M | 272.02M | 221.43M | 143.54M |
Operating income | -267.82M | -536.20M | -449.71M | -564.16M | -522.32M | -343.62M | -171.63M | -266.73M | -220.18M | -133.78M |
Other income (expenses), net | -252.27M | -153.76M | 30.76M | 11.09M | -191.55M | 10.13M | 123.01M | -2.54M | 154K | -2.00M |
Income before tax | -520.09M | -689.96M | -418.94M | -553.06M | -713.88M | -362.61M | -48.62M | -267.26M | -220.03M | -135.78M |
Income tax expense | 15.87M | 13.52M | -168K | 1.06M | 1.19M | -692K | 2.06M | -7.62M | -5.24M | -1.69M |
Net income | -535.97M | -703.48M | -418.78M | -554.12M | -715.07M | -361.91M | -50.68M | -267.26M | -220.03M | -135.78M |
Earnings per share | ||||||||||
Basic EPS | -5.8 | -8.03 | -5.15 | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 | -5.2 | -3.39 |
Diluted EPS | -5.8 | -8.03 | -5.15 | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 | -5.2 | -3.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |